CHRS
Coherus Onco (CHRS)
NASDAQ
$1.48+$0.005 (+0.34%)
Price as of Jun 03, 2026 7:56 PM EDT
  • $245.3M
    Market Cap
  • 94.37%
    1-Year Change
  • Biotechnology
    Industry

Earnings Score

N/A
Valuation
CHRS
vs History
vs S&P 500
Profitability
1
Growth
0
Low Earnings Volatility
5

Momentum Score

Score: 68
Valuation
CHRS
vs History
vs S&P 500
3-Month Momentum
4.85%
12-Month Momentum
121.23%
3-Month Risk Adjusted Momentum
18.10%
12-Month Risk Adjusted Momentum
154.69%

True Yield

N/A
Valuation
CHRS
vs History
vs S&P 500
Dividend Yield
N/A
Net Buyback Yield
N/A
Net Debt Paydown Yield
-0.06%

Financial Health Score

N/A
Valuation
CHRS
vs History
vs S&P 500
Ohlson's O-Score
8